Marvel Biosciences Corp (MRVL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2024 | 07-2023 | 07-2022 | 07-2021 | 07-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 4 | -25 | 3 | -23 | -36 |
| Other Working Capital | 185 | 879 | 360 | -115 | 32 |
| Other Operating Activity | -1,369 | -2,186 | -2,557 | -1,233 | -535 |
| Operating Cash Flow | $-1,179 | $-1,332 | $-2,194 | $-1,371 | $-539 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | 0 | 382 | 0 |
| Investing Cash Flow | $N/A | $N/A | $0 | $382 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 1,000 | N/A | N/A | N/A |
| Common Stock Issued | 500 | 270 | 420 | 3,181 | 758 |
| Other Financing Activity | -31 | 26 | -26 | -23 | 5 |
| Financing Cash Flow | $969 | $1,296 | $394 | $3,157 | $763 |
| Beginning Cash Position | 557 | 593 | 2,393 | 225 | 0 |
| End Cash Position | 346 | 557 | 593 | 2,393 | 225 |
| Net Cash Flow | $-211 | $-37 | $-1,800 | $2,168 | $225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,179 | -1,332 | -2,194 | -1,371 | -539 |
| Free Cash Flow | -1,179 | -1,332 | -2,194 | -1,371 | -539 |